eFFECTOR Therapeutics, Inc.

NASDAQ:EFTR

0.0002 (USD) • At close February 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 15.50814.8755.38614.71410.318.70811.90316.35317.66449.70254.76810.8816.77415.216-3.427
Short Term Investments 9.8753.49512.39310.3058.69717.60221.05324.68528.042000006.854
Cash and Short Term Investments 25.38318.3717.77925.01919.00726.3132.95641.03845.70649.70254.76810.8816.77415.2163.427
Net Receivables 000000000000.51.400
Inventory 00-0.023-0.072-0.0420-0.4-0.40-0.1-0.20000
Other Current Assets 0.8671.4681.5030.9561.8871.7042.5652.495.2666.3884.1730.654-1.1771.3620
Total Current Assets 26.2519.83819.28225.97520.89428.01435.52142.28348.33952.89658.94112.03416.99716.5783.427
Non-Current Assets:
Property, Plant & Equipment, Net 0.4150.1930.3120.2990.3110.3520.3710.3810.3020.2570.0450.0680.0970.1260
Goodwill 000000000000000
Intangible Assets 000000000000000
Goodwill and Intangible Assets 000000000000000
Long Term Investments 00000000000175.008000
Tax Assets 000000000000000
Other Non-Current Assets 0.4660.5130.5670.6150.7230.7110.7590.8070.8540.9030.95-172.8290.0560-3.427
Total Non-Current Assets 0.8810.7060.8790.9141.0341.0631.131.1881.1561.160.9952.2470.1530.126-3.427
Total Assets 27.13120.54420.16126.88921.92829.07736.65143.47149.49554.05659.93614.28117.1516.7040
Liabilities & Equity:
Current Liabilities:
Account Payables 1.7132.331.1361.4513.7941.4861.2141.2040.2940.5160.3211.9070.4580.3470
Short Term Debt 20.06920.54520.4720.38520.30320.22120.13920.0590.0920.0880.0560.05518.5596.0150
Tax Payables 00000.4730.4630.3510.3510.3510.3510.3510.3510.3510.3510
Deferred Revenue 000000-0.0540002.7482.6570.3511.9840
Other Current Liabilities 3.7872.9211.9821.9232.0822.9053.2641.9711.8933.02345.6190.4292.8462.0660
Total Current Liabilities 25.56925.79623.58823.75926.65225.07524.96823.5852.633.97846.3475.39922.5658.7790
Non-Current Liabilities:
Long Term Debt 0.35800.0120.050.0860.060.1540.18820.02519.98619.76319.66806.9460
Deferred Revenue Non-Current 000000000000000
Deferred Tax Liabilities Non-Current 000000000000000
Other Non-Current Liabilities 0.3770.5430.5270.5050.0030.046-0.0310.0751.60612.8081.495133.2240133.2240
Total Non-Current Liabilities 0.7350.5430.5390.5550.0890.1060.1230.26321.63132.79421.258152.89210.24140.170
Total Liabilities 26.30426.33924.12724.31426.74125.18125.09123.84824.26136.77267.605158.29122.565148.9490
Equity:
Preferred Stock 000000000059.936133.224133.224133.224133.224
Common Stock 000.0060.0060.00400.0040.0040.0040.0040.0040.0020.00100
Retained Earnings -188.211-179.377-170.247-161.944-153.58-143.566-134.306-124.747-117.832-120.901-139.95-148.829-143.281-136.6990
Accumulated Other Comprehensive Income/Loss 00-0.0010.0010.001-0.018-0.069-0.082-0.05-0-59.936-133.224-0.001-133.224-147.063
Other Total Stockholders Equity 189.038173.582166.276164.512148.762147.48145.931144.448143.1120132.2774.8174.642137.6780
Total Shareholders Equity 0.827-5.795-3.9662.575-4.8133.89611.5619.62325.23417.284-7.669-144.01-5.415-132.245-13.839
Total Equity 0.827-5.795-3.9662.575-4.8133.89611.5619.62325.23417.284-7.669-144.01-5.415-132.245-13.839
Total Liabilities & Shareholders Equity 27.13120.54420.16126.88921.92829.07736.65143.47149.49554.05659.93614.28117.1516.704-13.839